Important Announcement: CASPS – A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma
OPEN NOW: CASPS – A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma Sponsored by: The Institute of Cancer Research / The Royal Marsden NHS Foundation Trust Information provided by: The Institute of Cancer Research – Clinical Trials and Statistics Unit ClinicalTrials.gov Identifier: NCT01337401 Cediranib (AZD2171) is a […]